Increase of Synergistic Secondary Antiviral Mutations in the Evolution of A(H1N1)pdm09 Influenza Virus Neuraminidases
Viruses · 2024
DOI: 10.3390/v16071109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Susanne C Duwe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit 17 Influenza and Other Respiratory Viruses, Department 1 Infectious Diseases, Robert Koch-Institute, 13353 Berlin, Germany. Hauptthemen laut MEDLINE: Neuraminidase, Influenza A Virus, H1N1 Subtype, Antiviral Agents, Drug Resistance, Viral. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The unexpected emergence of oseltamivir-resistant A(H1N1) viruses in 2008 was facilitated in part by the establishment of permissive secondary neuraminidase (NA) substitutions that compensated for the fitness loss due to the NA-H275Y resistance substitution. These viruses were replaced in 2009 by oseltamivir-susceptible A(H1N1)pdm09 influenza viruses. Genetic analysis and screening of A(H1N1)pdm09 viruses circulating in Germany between 2009 and 2024 were conducted to identify any potentially synergistic or resistance-associated NA substitutions. Selected viruses were then subjected to further characterization in vitro. In the NA gene of circulating A(H1N1)pdm09 viruses, two secondary substitutions, NA-V241I and NA-N369K, were identified. These substitutions demonstrated a stable lineage in phylogenetic analysis since the 2010–2011 influenza season. The data indicate a slight increase in viral NA bearing two additional potentially synergistic substitutions, NA-I223V and NA-S247N, in the 2023–2024 season, which both result in a slight reduction in susceptibility to NA inhibitors. The accumulation of secondary synergistic substitutions in the NA of A(H1N1)pdm09 viruses increases the probability of the emergence of antiviral-resistant viruses. Therefore, it is crucial to closely monitor the evolution of circulating influenza viruses and to develop additional antiviral drugs against different target proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit 17 Influenza and Other Respiratory Viruses, Department 1 Infectious Diseases, Robert Koch-Institute, 13353 Berlin, Germany.
ORCID-Profile: Ralf Dürrwald
Zitieren
APA
Duwe, S. C., Milde, J., Heider, A., Wedde, M., Schweiger, B., & Dürrwald, R. (2024). Increase of Synergistic Secondary Antiviral Mutations in the Evolution of A(H1N1)pdm09 Influenza Virus Neuraminidases. Viruses. https://doi.org/10.3390/v16071109
Vancouver
Duwe SC, Milde J, Heider A, Wedde M, Schweiger B, Dürrwald R. Increase of Synergistic Secondary Antiviral Mutations in the Evolution of A(H1N1)pdm09 Influenza Virus Neuraminidases. Viruses. 2024. doi:10.3390/v16071109
BibTeX
@article{Duwe2024,
author = {Duwe, Susanne C and Milde, Jeanette and Heider, Alla and Wedde, Marianne and Schweiger, Brunhilde and Dürrwald, Ralf},
title = {Increase of Synergistic Secondary Antiviral Mutations in the Evolution of A(H1N1)pdm09 Influenza Virus Neuraminidases},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16071109}
}
EUVIMED